A: Sodium Nucinersen (12Mg 5Ml/1 Bottle) 2 Bottles, B: Satralizumab (Genetic Recombination) (120Mg 1Ml/1 Bottle) 47 Bottles, C: Lovelizumab (Genetic Recombination) (300Mg 3Ml/1 Bottle) 42 Bottles, D: Andexanet A.

Name: A: Sodium Nucinersen (12Mg 5Ml/1 Bottle) 2 Bottles, B: Satralizumab (Genetic Recombination) (120Mg 1Ml/1 Bottle) 47 Bottles, C: Lovelizumab (Genetic Recombination) (300Mg 3Ml/1 Bottle) 42 Bottles, D: Andexanet A.
Start: 2025-04-17
End: 2025-05-01
Location: 国立大学法人

国立大学法人 Japan has Released a tender for A: Sodium Nucinersen (12Mg 5Ml/1 Bottle) 2 Bottles, B: Satralizumab (Genetic Recombination) (120Mg 1Ml/1 Bottle) 47 Bottles, C: Lovelizumab (Genetic Recombination) (300Mg 3Ml/1 Bottle) 42 Bottles, D: Andexanet A. in Healthcare and Medicine. The tender was released on Apr 16, 2025.

Country - Japan

Summary - A: Sodium Nucinersen (12Mg 5Ml/1 Bottle) 2 Bottles, B: Satralizumab (Genetic Recombination) (120Mg 1Ml/1 Bottle) 47 Bottles, C: Lovelizumab (Genetic Recombination) (300Mg 3Ml/1 Bottle) 42 Bottles, D: Andexanet A.

Deadline - May 01, 2025

GT reference number - 107053221

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

Address - Japan

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 107053221

Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: A: Sodium Nucinersen (12Mg 5Ml/1 Bottle) 2 Bottles, B: Satralizumab (Genetic Recombination) (120Mg 1Ml/1 Bottle) 47 Bottles, C: Lovelizumab (Genetic Recombination) (300Mg 3Ml/1 Bottle) 42 Bottles, D: Andexanet A.local title:: Ａ　ヌ� ��ネルセンナトリウム（12mg５㎖／１瓶）　２瓶、Ｂ　サトラリズマブ（遺伝子組換え）（120mg１㎖／１筒）　47筒、Ｃ　ラブリズマブ（遺伝子組換え）（300mg３㎖／１瓶）　42瓶、Ｄ　アンデキサネット　ア.local description: : 入札公告次のとおり一般競争入札に付します。令和７年４月　16　日分任契約責任者国立大学法人富山大学財務施�

Gt Ref Id - 107053221

Deadline - May 01, 2025